CRP and myocardial infarction: Patients with higher CRP levels (CRP > 3 mg/dL) were associated with a significantly increased rate of MACE which included all-cause death, recurrence of nonfatal myocardial infarction, and target vessel revascularization (TVR) in terms of long-term clinical outcome.